• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自牺牲型金属有机框架用于双膦酸盐类抗骨质疏松药物的超长控制释放。

Self-sacrificial MOFs for ultra-long controlled release of bisphosphonate anti-osteoporotic drugs.

机构信息

Crystal Engineering, Growth and Design Laboratory, Department of Chemistry, University of Crete, Heraklion, Crete, GR-71003, Greece.

Biochemistry Laboratory, Department of Chemistry, University of Crete, Heraklion, Crete, GR-71003, Greece.

出版信息

Chem Commun (Camb). 2020 May 11;56(38):5166-5169. doi: 10.1039/d0cc00439a. Epub 2020 Apr 7.

DOI:10.1039/d0cc00439a
PMID:32255461
Abstract

In this paper we report drug delivery systems that are based on phosphonate MOFs. These employ biologically-acceptable metal ions (e.g. Ca and Mg) and several anti-osteoporosis bisphosphonate drugs (etidronate, pamidronate, alendronate and neridronate), as the organic linkers. These materials have been synthesized, structurally characterized, and studied for the self-sacrificial release (by pH-driven dissolution) of the bisphosphonate active ingredient. They exhibit variable release rates and final % release, depending on the actual structure of the metal-bisphosphonate material. Their cytotoxicity profiles match those of the active ingredients.

摘要

本文报道了基于膦酸酯 MOF 的药物传递系统。这些系统采用生物可接受的金属离子(如 Ca 和 Mg)和几种抗骨质疏松双膦酸盐药物(依替膦酸、帕米膦酸、阿仑膦酸和奈立膦酸)作为有机连接体。这些材料已经被合成、结构表征,并研究了它们在自牺牲释放(通过 pH 驱动的溶解)双膦酸盐活性成分的性能。它们的释放速率和最终的%释放率因金属-双膦酸盐材料的实际结构而异。它们的细胞毒性谱与活性成分相匹配。

相似文献

1
Self-sacrificial MOFs for ultra-long controlled release of bisphosphonate anti-osteoporotic drugs.自牺牲型金属有机框架用于双膦酸盐类抗骨质疏松药物的超长控制释放。
Chem Commun (Camb). 2020 May 11;56(38):5166-5169. doi: 10.1039/d0cc00439a. Epub 2020 Apr 7.
2
Smart, programmable and responsive injectable hydrogels for controlled release of cargo osteoporosis drugs.用于控制载药(治疗骨质疏松症药物)释放的智能、可编程和响应型可注射水凝胶。
Sci Rep. 2017 Jul 6;7(1):4743. doi: 10.1038/s41598-017-04956-3.
3
Structural Diversity in Antiosteolytic Bisphosphonates: Deciphering Structure-Activity Trends in Ultra Long Controlled Release Phenomena.抗骨吸收双膦酸盐的结构多样性:解析超长控释现象中的结构-活性趋势。
ACS Appl Bio Mater. 2023 Dec 18;6(12):5563-5581. doi: 10.1021/acsabm.3c00770. Epub 2023 Nov 20.
4
Design, Synthesis, and Pharmacokinetics of a Bone-Targeting Dual-Action Prodrug for the Treatment of Osteoporosis.用于治疗骨质疏松症的骨靶向双功能前药的设计、合成及药代动力学
J Med Chem. 2017 Aug 24;60(16):7012-7028. doi: 10.1021/acs.jmedchem.6b00951. Epub 2017 Aug 10.
5
Bisphosphonate protonation states, conformations, and dynamics on bone mineral probed by solid-state NMR without isotope enrichment.无同位素富集的固态 NMR 探测骨矿物质上的双膦酸盐质子化状态、构象和动力学。
Eur J Pharm Biopharm. 2010 Sep;76(1):120-6. doi: 10.1016/j.ejpb.2010.05.013. Epub 2010 Jun 8.
6
[New therapy using bisphosphonate for urolithiasis].[双膦酸盐治疗尿路结石的新疗法]
Clin Calcium. 2011 Oct;21(10):1511-5.
7
Drug-Inclusive Inorganic-Organic Hybrid Systems for the Controlled Release of the Osteoporosis Drug Zoledronate.用于控制释放在骨质疏松症药物唑来膦酸的药物包容型无机-有机杂化体系。
Molecules. 2022 Sep 21;27(19):6212. doi: 10.3390/molecules27196212.
8
Determination of bisphosphonate active pharmaceutical ingredients in pharmaceuticals and biological material: a review of analytical methods.药物和生物材料中双膦酸盐活性药物成分的测定:分析方法综述
J Pharm Biomed Anal. 2008 Nov 4;48(3):483-96. doi: 10.1016/j.jpba.2008.05.028. Epub 2008 Jul 2.
9
Synthesis, properties, and perspectives of gem-diphosphono substituted-thiazoles.偕二膦酸取代噻唑的合成、性质及展望
Eur J Med Chem. 2008 May;43(5):1015-24. doi: 10.1016/j.ejmech.2007.07.005. Epub 2007 Jul 27.
10
Alkaline Earth Metal-Organic Frameworks with Tailorable Ion Release: A Path for Supporting Biomineralization.具有可调节离子释放功能的碱土金属有机骨架:支持生物矿化的一种途径。
ACS Appl Mater Interfaces. 2019 Sep 11;11(36):32739-32745. doi: 10.1021/acsami.9b11004. Epub 2019 Aug 27.

引用本文的文献

1
Biomedical Applications of Functionalized Composites Based on Metal-Organic Frameworks in Bone Diseases.基于金属有机框架的功能化复合材料在骨疾病中的生物医学应用
Pharmaceutics. 2025 Jun 8;17(6):757. doi: 10.3390/pharmaceutics17060757.
2
Calcium Medronate-Based Metal-Organic Frameworks as Multifunctional Biomaterials.基于甲磺酸氯屈膦酸盐的金属有机框架作为多功能生物材料。
Cryst Growth Des. 2025 Feb 20;25(5):1415-1422. doi: 10.1021/acs.cgd.4c01478. eCollection 2025 Mar 5.
3
Metal Pyrazolyl-Diphosphonate Pillared Materials as Heterogeneous Catalysts in the Mukaiyama-Type Aerobic Olefin Epoxidation.
金属吡唑基二膦酸支柱材料作为 Mukaiyama 型有氧烯烃环氧化反应中的多相催化剂
Chemistry. 2025 Jan 27;31(6):e202403756. doi: 10.1002/chem.202403756. Epub 2024 Nov 27.
4
Metal-organic frameworks: Drug delivery applications and future prospects.金属有机框架:药物递送应用及未来前景。
ADMET DMPK. 2023 Nov 17;12(1):27-62. doi: 10.5599/admet.2057. eCollection 2024.
5
A Facile Crystallization Strategy to Turn Calcium Bisphosphonates into Novel Osteogenesis-Inducing Biomaterials.一种将双膦酸盐转化为新型成骨诱导生物材料的简便结晶策略。
Adv Healthc Mater. 2023 Sep;12(22):e2203004. doi: 10.1002/adhm.202203004. Epub 2023 Jun 7.
6
Surface-Modified Silica Hydrogels for the Programmable Release of Bisphosphonate Anti-Osteoporosis Drugs: The Case of Etidronate.用于双膦酸盐抗骨质疏松药物可编程释放的表面改性二氧化硅水凝胶:以依替膦酸为例
Materials (Basel). 2023 Apr 26;16(9):3379. doi: 10.3390/ma16093379.
7
How Efficient are Alendronate-Nano/Biomaterial Combinations for Anti-Osteoporosis Therapy? An Evidence-Based Review of the Literature.阿仑膦酸钠-纳米/生物材料组合在抗骨质疏松治疗中的效率如何?基于证据的文献综述。
Int J Nanomedicine. 2022 Dec 6;17:6065-6094. doi: 10.2147/IJN.S388430. eCollection 2022.
8
Drug-Inclusive Inorganic-Organic Hybrid Systems for the Controlled Release of the Osteoporosis Drug Zoledronate.用于控制释放在骨质疏松症药物唑来膦酸的药物包容型无机-有机杂化体系。
Molecules. 2022 Sep 21;27(19):6212. doi: 10.3390/molecules27196212.
9
Exploiting the Multifunctionality of M/Imidazole-Etidronates for Proton Conductivity (Zn) and Electrocatalysis (Co, Ni) toward the HER, OER, and ORR.利用M/咪唑-依替膦酸盐的多功能性实现质子传导(锌)以及对析氢反应(HER)、析氧反应(OER)和氧还原反应(ORR)的电催化(钴、镍)。
ACS Appl Mater Interfaces. 2022 Mar 9;14(9):11273-11287. doi: 10.1021/acsami.1c21876. Epub 2022 Feb 22.
10
Metal-organic frameworks for advanced drug delivery.用于先进药物递送的金属有机框架材料。
Acta Pharm Sin B. 2021 Aug;11(8):2362-2395. doi: 10.1016/j.apsb.2021.03.019. Epub 2021 Mar 13.